Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

NCT05212857 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Leuprolide acetate
DRUG: Goserelin acetate
DRUG: Triptorelin acetate
DRUG: Degarelix acetate
DRUG: Abiraterone acetate
DRUG: Apalutamide
DRUG: Enzalutamide
PROCEDURE: Local treatment for primary lesion
RADIATION: Radiotherapy for primary lesion
RADIATION: Radiotherapy for metastatic lesion

Sponsor

Fudan University